This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Serology of HIV infection

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

laboratory markers of HIV infection

Analyses of specimens from seroconversion panels have led to the understanding of HIV-1 viremia after infection and the sequential appearance of different laboratory markers:

  • immediately after HIV infection
    • low levels of HIV-1 RNA might be present intermittently
    • no viral markers can be detected consistently in plasma

  • approximately 10 days after infection
    • HIV-1 RNA becomes detectable by nucleic acid test (NAT) in plasma and quantities increase to very high levels

  • within 4 to 10 days after the initial detection of HIV-1 RNA
    • HIV-1 p24 antigens is expressed and quantities rise to levels that can be detected by 4th generation immunoassays
      • however this is transient since antibodies begin to develop and bind to the p24 antigen and form immune complexes the interferes with p24 assay detection

  • 3 to 5 days after p24 antigen is first detectable (10 to 13 days after the appearance of viral RNA)
    • immunoglobulin (Ig) M antibodies are expressed which can be detected by 3rd and 4th generation immunoassays

  • finally, IgG antibodies appear and persist throughout the course if HIV infection

The pattern of emergence of laboratory markers is highly consistent. This has led to classification of HIV infection into distinct laboratory stages:

  • the eclipse period - period after infection when no laboratory markers are consistently detectable
  • seroconversion window period - interval between infection with HIV and the first detection of antibodies.
  • acute HIV infection - period between the appearance of detectable HIV RNA and the first detection of antibodies
  • established HIV infection - characterized by a fully developed IgG antibody response sufficient to meet the interpretive criteria for a positive Western blot or IFA (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.